2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propanenitrile, 97%, 100mg

Glass vials with rolled rim, 35 ml, Height, 65 mm, 200 Piece(s)

5-(Trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid, 95.0%, 250mg

3-Bromo-7,8-dihydro-1,6-naphthyridin-5(6H)-one, 98%, 5g

2-Chloro-5-(trifluoromethyl)aniline hydrochloride, 95.0%, 250mg

(S)-2-Amino-2-(bicyclo[1.1.1]pentan-1-yl)acetic acid hydrochloride, 97%, 100mg

N-Succinimidyl 7-Methoxycoumarin-3-carboxylate>98.0%(HPLC)(N)1g

(2R,3S,4R)-2,3,4,5-tetrahydroxypentanoic acid, 98%, 100mg

phenylboronic acid hydrate, 95.0%, 100g

{[4-(TRIFLUOROMETHYL)PHENYL]METHYLHYDRAZINE HCL, 95.0%, 5g

3-Bromophenylboronic acid, 98.0%, 5g

4-Amino-5-bromo-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one, 95.0%, 1g

Methyl 6-oxoheptanoate, 95.0%, 5g